USP42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.114400E-01
Normal-vs-Stage2
6.892000E-01
Normal-vs-Stage3
1.971840E-02
Normal-vs-Stage4
3.528200E-01
Stage1-vs-Stage2
1.731160E-01
Stage1-vs-Stage3
2.726400E-02
Stage1-vs-Stage4
6.211200E-01
Stage2-vs-Stage3
5.230100E-02
Stage2-vs-Stage4
6.991800E-02
Stage3-vs-Stage4
2.199900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.109200E-01
Normal-vs-AfricanAmerican
9.214000E-01
Normal-vs-Asian
6.898400E-01
Caucasian-vs-AfricanAmerican
5.181600E-01
Caucasian-vs-Asian
8.213000E-01
AfricanAmerican-vs-Asian
5.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.766600E-01
Normal-vs-Female
8.402600E-01
Male-vs-Female
3.572000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.085000E-01
Normal-vs-Age(41-60Yrs)
7.023200E-01
Normal-vs-Age(61-80Yrs)
5.106400E-01
Normal-vs-Age(81-100Yrs)
3.877000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.366600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.726000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.156300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.436700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.120300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.618000E-01
Normal-vs-Daily Drinker
3.349800E-01
Normal-vs-Weekly Drinker
9.618400E-01
Normal-vs-Occasional Drinker
9.762600E-01
Normal-vs-Social Drinker
7.126600E-01
Non Drinker-vs-Daily Drinker
8.548400E-01
Non Drinker-vs-Weekly Drinker
1.062220E-01
Non Drinker-vs-Occasional Drinker
3.529700E-02
Non Drinker-vs-Social Drinker
8.036500E-03
Daily Drinker-vs-Weekly Drinker
1.820770E-01
Daily Drinker-vs-Occasional Drinker
7.752300E-02
Daily Drinker-vs-Social Drinker
2.259600E-02
Weekly Drinker-vs-Occasional Drinker
8.925000E-01
Weekly Drinker-vs-Social Drinker
5.481600E-01
Occasional Drinker-vs-Social Drinker
5.675800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.403200E-01
Normal-vs-Grade 2
7.108200E-01
Normal-vs-Grade 3
6.543400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.763600E-01
Grade 1-vs-Grade 3
9.799600E-01
Grade 1-vs-Grade 4
3.403200E-01
Grade 2-vs-Grade 3
1.889000E-01
Grade 2-vs-Grade 4
7.108200E-01
Grade 3-vs-Grade 4
6.543400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.577400E-01
Normal-vs-NonDiabetic
7.392000E-01
Diabetic-vs-NonDiabetic
1.653170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.179600E-01
Normal-vs-NoPancreatitis
6.568800E-01
Pancreatitis-vs-NoPancreatitis
6.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.012600E-01
Normal-vs-N1
7.225400E-01
N0-vs-N1
7.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.780200E-01
Normal-vs-TP53-NonMutant
7.979400E-01
TP53-Mutant-vs-TP53-NonMutant
7.615600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
